Skip to main content
  • 51 Accesses

Abstract

Sponsors of phase III HIV vaccine trials in developing nations may ask to be excused from the requirement to fully inform each individual prospective subject and to obtain each individual prospective subject’s free and uncoerced consent. They could base their request on the difficulty (or impossibility) of explaining such complex material to persons in communities with less than optimum literacy, and/or on the length of time it would take to so educate each individual subject. They might also base their request on the perceived difficulty of finding large numbers of persons who are “so situated as to be able to exercise free power of choice,” i.e., who are completely free of any possibility of coercion, constraint, duress, or intimidation. That is, they could ask instead to invoke the principle of proxy consent.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Copyright information

© 1997 Thomas A. Kerns

About this chapter

Cite this chapter

Kerns, T.A. (1997). Proxy Consent?. In: Ethical Issues in HIV Vaccine Trials. Palgrave Macmillan, London. https://doi.org/10.1057/9780230380011_20

Download citation

Publish with us

Policies and ethics